Dual label immunohistochemical study of interleukin-4- and interferon-γ-expressing cells within the pancreas of the NOD mouse during disease acceleration with cyclophosphamide

Autoimmunity

Volumn 32, Issue 3, 2000, Pages

  Reddy, S ^a   Karanam, M ^a   Poole, C A ^a   Ross, J M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Co localization; Cyclophosphamide; Cytokines; Diabetes; NOD mouse; Pancreatic islets

Indexed keywords

CYCLOPHOSPHAMIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; CELL DESTRUCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0033677281     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916930008994091     Document Type: Article

References (60)

1. The 'natural' history of type 1 diabetes
2. Insulin-dependent diabetes mellitus as an autoimmune disease
3. The murine autoimmune diabetes model: NOD and related strains
4. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice
5. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and ̄-cell destruction in NOD mice
6. Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse
7. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide
8. Immune disturbance and pathogenesis of non-obese diabetes-prone (NOD) mice
9. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide
10. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans
11. Inhibition of insulin secretion by interleukin-1̄ and tumour necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism
12. Inhibitory effects of interleukin-1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets
13. Cytokines and free radicals as effector molecules in the destruction of pancreatic beta cells
14. TNF-α and INF-γ potentiate the deleterious effects of IL-1β on mouse pancreatic islets mainly via generation of nitric oxide
15. Cytokines suppress islet function irrespective of their effects on nitric oxide generation
16. Human pancreatic islet β-cell destruction by cytokines is independent of nitric oxide production
17. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins
18. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
19. Roles of cytokines in IDDM pathogenesis and islet β-cell destruction
20. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation
21. Tumour necrosis factor-α and interferon-γ inhibit insulin secretion and cause DNA damage in unweaned-rat islets: Extent of nitric oxide involvement
22. Apoptosis is the mode of β-cell death responsible for the development of IDDM in the non-obese diabetic (NOD) mouse
23. Apoptosis and beta cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes
24. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus
25. IL-4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in NOD mice
26. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in non-obese diabetic mice
27. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin-E
28. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in non-obese diabetic mice
29. Interleukin 12 mRNA expression in islets correlates with β-cell destruction in NOD mice
30. Both TH1 and TH2 cytokine mRNAs are expressed in the NOD mouse pancreas in vivo
31. IL-4 expression at the onset of islet inflammation predicts non-destructive insulitis in nonobese diabetic mice
32. β-Cell destruction may be a late consequence of the autoimmune process in non-obese diabetic mice
33. Genes encoding tumour necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes
34. Regulation of lymphokine mRNA stability by a surface-mediated T cell activation pathway
35. Cycophosphamided treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not interleukin-4
36. Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-γ expression involved in the development of Th1 insulitis in NOD mice
37. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes
38. + T-cells in syngeneic islet grafts in NOD mice produce interferon-γ during β-cell destruction
39. Administration of silica particles or anti-Lyt2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide
40. The effect of cyclophosphamide treatment on lymphocyte subsets in the non-obese diabetic mouse: A comparison of various lymphoid organs
41. Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the nonobese diabetic mouse
42. Inducible nitric oxide synthase in pancreatic islets of the non-obese diabetic mouse: A light and confocal microscopical study of its ontogeny, co-localization and up-regulation following cytokine administration
43. Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes
44. Reduced incidence and delayed onset of diabetes in perforin-deficient non-obese diabetic mice
45. Cell death mediators in autoimmune diabetes - No shortage of suspects
46. The role of Fas in autoimmune diabetes
47. Fas-FasL interactions: A common pathogenetic mechanism in organ-specific autoimmunity
48. Monokine-producing cells predominate in the recruitment phase of NOD insulitis while cells producing Th1-type cytokines characterize the effector phase
49. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man- macrophages, lymphocytes, and interferon-γ containing cells
50. Islet expression of interferon-α precedes diabetes in both the BB rat and streptozotocin-treated mice
51. Immunoreactive α-interferon in insulin-secreting β cells in type 1 diabetes mellitus
52. Interferon expression in the pancreases of patients with type 1 diabetes
53. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-KB activation
54. Murine macrophages secrete interferon γ upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation
55. Induction of IFN-γ in macrophages by lipopolysaccharide
56. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice
57. Prevention of diabetes in NOD mice treated with antibody to murine IFNγ
58. The effects of a nonimmunogenic form of murine soluble interferon-γ receptor on the development of autoimmune diabetes in the NOD mouse
59. Genetic absence of γ-inteferon delays but does not prevent diabetes in NOD mice
60. α-Interferon inhibits the development of diabetes in NOD mice